: The Biotech Balancing Act: Scaling Science, Team & Vision with Liesbeth Ceelen from Biolizard

entrepreneurship
co:lab podcast logo

In this new episode of the 𝗰𝗼:𝗹𝗮𝗯 𝗽𝗼𝗱𝗰𝗮𝘀𝘁, Liesbeth Ceelen, CEO of Biolizard, joins Olivier Van Raemdonck to share the remarkable story behind one of -Belgium’s fastest-growing biotech data consultancies.

blue dots of co:lab

From its early days as a five-person team to now supporting over 90 clients across Europe and the U.S., Liesbeth walks us through Biolizard’s unique approach: combining cutting-edge data science with deep biological insight to accelerate drug and biomarker development.

You will hear how Liesbeth built a diverse, values-driven team of 50+ scientists, navigated international expansion, and still found time to balance leadership with family life. Whether you're in biotech, data, or leading a growing team, this conversation offers unique insight into building a company that scales without losing its soul.

 

other podcasts

photo of Nico Huybrechts during co:lab podcast
Season 2 Episode 8
Scaling Datashift: Nico Huybrechts on Growth, Governance and AI 
In the final episode of this co:lab season, we sit down with Nico Huybrechts, founder and CEO of Datashift. Ten years ago, Datashift started at the kitchen table. Today, it is a multidisciplinary data & AI consultancy operating across borders. But this conversation goes beyond numbers.
podcast colab ep.7 - Leen Limbourg
Season 2 Episode 7
How life sciences innovation survives uncertainty with investor Leen Limbourg
In this episode of co:lab, we speak with Leen Limbourg, medical doctor, investor and experienced board member, about the realities of building and funding life sciences companies in today’s challenging environment.